-
SW033291: Reliable 15-PGDH Assay Workflows
2026-09-15
Learn how SW033291 (SKU A8709) can improve experimental consistency in 15-PGDH, prostaglandin E2, hematopoietic, and tissue regeneration studies. This scenario-based guide covers assay design, compound handling, interpretation, and practical vendor-selection criteria.
-
MK-0812 for Causal Mapping of MASH Inflammation
2026-09-15
MK-0812 provides a selective pharmacological route to test whether CCR2-dependent monocyte recruitment contributes to MASH. This article integrates MK-0812 with the intestinal TM6SF2 gut–liver model to define stronger assay logic, experimental controls, and evidence boundaries.
-
TAK-715: A Practical p38 MAPK Inhibitor Workflow
2026-09-14
TAK-715 combines nanomolar p38α selectivity with a workflow-friendly profile for cytokine, stress-response, and inflammation studies. Its greatest value is experimental precision: researchers can separate direct kinase blockade from downstream changes in phosphorylation and cytokine release across cellular and animal models.
-
CSBTA Pharmacokinetics in MASH: Key Findings
2026-09-14
The 2025 Biomedicine & Pharmacotherapy study integrates pharmacokinetics, tissue distribution, cellular uptake, and enzyme–transporter analysis to explain why Corydalis saxicola Bunting total alkaloids behave differently in HFHCD-induced MASH mice. Its findings show that disease state and repeated dosing increase exposure to key alkaloids, offering a mechanistic framework for dose-regimen design and pharmacokinetic variability research.
-
Aβ25-35: From Neurotoxicity Model to AD Translation
2026-09-13
A strategic guide to using Amyloid Beta-peptide (25-35) as a controlled neurotoxic challenge, while connecting neuronal injury assays with the FLOT1–FOSL2–EphA2 inflammatory axis identified in recent Alzheimer’s disease research.
-
Anti-HMGB1 Rabbit Monoclonal Antibody Guide
2026-09-12
The Anti-HMGB1 Rabbit Monoclonal Antibody, SKU MA3057, provides a research reagent for detecting HMGB1 in human, mouse, and rat samples by Western blot, immunohistochemistry, and flow cytometry. It should be used for controlled scientific workflows only, with assay-specific optimization, and not for diagnosis, patient testing, or therapeutic decisions.
-
Reserpine (N1867): Practical Lab Workflow Guide
2026-09-12
Reserpine (SKU N1867) provides a defined research compound for neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology workflows where controlled preparation and solution handling are required. It is for research use only and should not be used for diagnostic, clinical, veterinary, or medical applications.
-
Gamma-linolenic Acid: Applied Research Workflows
2026-09-11
Build reproducible GLA experiments that connect LTB4-receptor binding, inflammatory signaling, and cell viability in one workflow. This guide also adapts a resistance-surveillance framework to improve assay metadata, controls, and translational interpretation.
-
Moraxella Recovery from Bovine Specimens
2026-09-11
Laura G. Leger’s University of Nebraska–Lincoln thesis develops Moraxella Selective Vancomycin Agar to reduce contamination and improve recovery of Moraxella species from bovine ocular specimens. The work also characterizes previously unresolved isolates, expanding the species-level view of organisms that may contribute to infectious bovine keratoconjunctivitis.
-
Nutlin-3a: Reliable MDM2 Inhibitor Assays
2026-09-10
Learn how Nutlin-3a, SKU A3671, can improve the interpretation and reproducibility of p53-focused viability, proliferation, and cytotoxicity experiments. This scenario-based guide covers mechanism, dose design, stock preparation, data interpretation, and practical vendor selection.
-
Vancomycin Hydrochloride: Mechanism & Research Use
2026-09-10
Vancomycin hydrochloride is a glycopeptide antibacterial agent and bacterial cell wall synthesis inhibitor for Gram-positive bacteria inhibition studies. Its defined D-alanyl-D-alanine target, product specifications, and reported Clostridium difficile infection model make it useful for antibiotic resistance assay design when its spectrum and formulation limits are controlled.
-
Fludarabine Workflows for Cancer Cell Assays
2026-09-09
Fludarabine supports mechanism-resolved viability, cell-cycle, and apoptosis workflows in leukemia and multiple myeloma models. Its most differentiated application is a carefully controlled extension into lymphodepletion and neoantigen-presentation studies, where chemotherapy schedule, HLA-I measurement, and T-cell killing must be interpreted together.
-
IGF2BP1–TUBB4B Signaling in Liver Fibrosis
2026-09-09
The reference study identifies an m6A-dependent IGF2BP1–TUBB4B–FAK pathway that promotes hepatic stellate cell activation, proliferation, and migration. By integrating transcriptomic, RNA-binding, methylation, genetic, and pharmacological evidence, it links RNA stabilization to a functional fibrogenic phenotype and provides a framework for pathway-level validation.
-
Phosbind Biotin for Dynamic Phosphorylation Mapping
2026-09-08
Phosbind Biotin can extend Western Blot detection of phosphorylated proteins from a single target assay to dynamic pathway analysis. This article uses the OsCPK4–OsCNGC7 rice salt-response study to explain what phosphate-capture data can reveal, and where orthogonal validation remains essential.
-
WSP-5 for Live-Cell H2S Imaging
2026-09-08
WSP-5 converts hydrogen sulfide reactivity into a rapid turn-on fluorescence signal, enabling spatial and time-resolved measurements that bulk assays can miss. This guide translates diabetic cardiomyopathy findings into practical workflows for endogenous H2S, donor-release experiments, and live-cell optimization.